CN1051008C - Chinese medicine composite for coronary heart disease and angina - Google Patents
Chinese medicine composite for coronary heart disease and angina Download PDFInfo
- Publication number
- CN1051008C CN1051008C CN94115183A CN94115183A CN1051008C CN 1051008 C CN1051008 C CN 1051008C CN 94115183 A CN94115183 A CN 94115183A CN 94115183 A CN94115183 A CN 94115183A CN 1051008 C CN1051008 C CN 1051008C
- Authority
- CN
- China
- Prior art keywords
- radix
- content
- chinese medicine
- rhizoma
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a Chinese medicine composition, particularly to the Chinese medicine composition for treating coronary heart disease and angina pectoris. The Chinese medicine composition for treating the coronary heart disease and the angina pectoris provided by the present invention is prepared from raw materials of the following weight proportion: 10 to 20 % of astragalus root, 8 to 16 % of danshen root, 2 to 8 % of angelica, 2 to 8 % of hemlock parsley, 4 to 8 % of safflower, 4 to 12 % of rhizoma corydalis, 6 to 10 % of largehead atractylodesrhizome, 7 to 12 % of snakegourd fruit, 2 to 7 % of cassia twig, 2 to 10 % of drug sweetflag rhizome, 2 to 8 % of polygalae, 4 to 10 % of jujube seed and 2 to 6 % of liquoric root. The present invention has the advantages that the Chinese medicine composition can be used for symptomatic treatment by aiming at different etiological factors, and therefore, the cure rate is greatly higher than that of other medicine. The Chinese medicine composition can also be used for restoring cardiac functions, and simultaneously can be accepted by a plurality of patients because of the low price of products.
Description
The present invention relates to a kind of Chinese medicine composition, particularly a kind of treatment coronary heart disease, anginal Chinese medicine composition.
The current coronary heart disease commonly encountered diseases that become international because this disease is sudden strong, so often have little time treatment during outbreak, uses existing Chinese medicine and western medicine also to be difficult to healing.The Chinese patent medicine of treatment coronary heart disease commonly used has SHANHAI PILL, compound recipe Buxus sinica (Rehd.et Wils.) sheet at present, the former adopts the theoretical point view that nourishes blood with blood in the theory of Chinese medical science and establishes, and is better to treatment blood-deficiency type coronary heart disease curative effect, but cures various types of coronary heart disease with it, curative effect is also not exclusively satisfied, and price is more expensive; And the latter serves as that the master makes tablet with the medicinal part of Buxus sinica (Rehd.et Wils.), but Buxus sinica (Rehd.et Wils.) is the endemicity Chinese herbal medicine, and its pharmacology, nature and flavor, the few people of toxic and side effects understand, and make the fixed tablet of composition again, can not be because of patient's different cause of disease symptomatic treatments.
The object of the present invention is to provide a kind of can be at the dissimilar coronary heart disease of different etiological treatments, recover cardiac function, and cure rate height, Chinese medicine composition that price is low.
Treatment coronary heart disease provided by the invention, anginal Chinese medicine composition include: the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, Fructus Trichosanthis, Ramulus Cinnamomi, Rhizoma Acori Graminei, Radix Polygalae, Semen Ziziphi Spinosae, Radix Glycyrrhizae, and the shared weight ratio of each component is:
Radix Astragali 10-20%
Radix Salviae Miltiorrhizae 8-16%
Radix Angelicae Sinensis 2-8%
Rhizoma Chuanxiong 2-8%
Flos Carthami 4-8%
Rhizoma Corydalis 4-12%
Rhizoma Atractylodis Macrocephalae 6-10%
Fructus Trichosanthis 7-12%
Ramulus Cinnamomi 2-7%
Rhizoma Acori Graminei 2-10%
Radix Polygalae 2-8%
Semen Ziziphi Spinosae 4-10%
Radix Glycyrrhizae 2-6%
Treatment coronary heart disease provided by the invention, anginal Chinese medicine composition at the different causes of disease, can also add the Chinese medicine composition that other composition is made series.One of them can also contain: Rhizoma Zingiberis, Bulbus Allii Macrostemonis, Rhizoma Zingiberis content are that 4-8%, Bulbus Allii Macrostemonis content are 4-12%.
Wherein two can also contain crust halberd, Cortex Cinnamomi, crust halberd content is that 4-15%, Cortex Cinnamomi content are 2-8%.
Wherein three can also contain Radix Scutellariae, Rhizoma Coptidis, Radix Puerariae, Radix Scutellariae content is that 4-12%, Rhizoma Coptidis content are that 4-12%, Radix Puerariae content are 4-12%.
Wherein four can also contain Radix Bupleuri, Radix Gentianae, Concha Haliotidis, Radix Bupleuri content is that 2-8%, Radix Gentianae content are 2-8%, Concha Haliotidis 4-8%.
Wherein five can also contain the Rhizoma Pinelliae, Bulbus Fritillariae Cirrhosae, Rhizoma Pinelliae content is that 2-6%, Bulbus Fritillariae Cirrhosae content are 4-8%.
Wherein six can also contain succinum, Olibanum, Myrrha, succinum content is that 1-4%, Olibanum content are 4-8%, Myrrha 4-12%.
Adopt Chinese medicine composition of the present invention, treat all types of coronary heart disease, angina pectoris, through clinical practice in 5 years, and 150 people are wherein carried out tracing observation, therapeutic effect is obvious, sees table:
The short term effect statistical table
| Efficacy evaluation | Observe total number of persons | Produce effects | Improve | Invalid | Increase the weight of | Effectively total | |
| The symptom curative effect | Number | 150 | 96 | 50 | 4 | 146 | |
| ％ | 64 | 33.3 | 2.7 | 97.3 | |||
| ECG curative effect | Number | 150 | 65 | 71 | 14 | 136 | |
| ％ | 43.4 | 47.3 | 9.3 | 90.7 | |||
Warp is to the long-term observation in 3 months-3 years of 94 people in addition, and relapse rate only is 15.9%, truly has the recovery cardiac function thereby further confirmed the present invention, even fundamentally cures all types of coronary heart disease, anginal effect.
The invention has the advantages that, can be at different cause of disease symptomatic treatments, thus cure rate is much higher than other medicines, but also can recover cardiac function, product price is lower simultaneously, can be accepted by extensive patients.
Embodiments of the invention are provided below:
Embodiment 1: the cause of disease belongs to cold coagulation when being main, and the composition of Chinese medicine composition of the present invention and proportioning are; The Radix Astragali 10%, Radix Salviae Miltiorrhizae 10%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 6%, Rhizoma Corydalis 6%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 4%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 8%, Radix Glycyrrhizae 4%, Rhizoma Zingiberis 6%, Bulbus Allii Macrostemonis 8%, each component weight sum is 100%.Adopt the method for the existing Chinese medicine electuary of purchasing that Chinese medicine composition is made electuary.
Embodiment 2: the cause of disease belongs to cold coagulation when being insufficiency of kidney-YANG in main, then the component with embodiment 1 is adjusted into: Fructus Trichosanthis 7%, Rhizoma Acori Graminei 4%, Radix Polygalae 3%, Rhizoma Zingiberis 4%, Bulbus Allii Macrostemonis 5%, crust halberd 5%, Cortex Cinnamomi 4%, other component and constant rate each component weight sum are 100%.Production method is identical with embodiment 1.
Embodiment 3: when the cause of disease belongs to the pathogenic fire criminal heart, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 8%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 5%, Rhizoma Corydalis 6%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 5%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 6%, Radix Glycyrrhizae 4%, Radix Scutellariae 6%, Rhizoma Coptidis 6%, Radix Puerariae 6%, each component weight sum is 100%.With the existing method for preparing Chinese medicinal tablet Chinese medicine composition is made tablet.
Embodiment 4: the cause of disease belongs to pathogenic fire when violating in the heart flaming up of liver-fire, then the component with embodiment 3 is adjusted into: Radix Angelicae Sinensis 2%, Rhizoma Chuanxiong 5%, Ramulus Cinnamomi 2%, Semen Ziziphi Spinosae 4%, Radix Scutellariae 5%, Rhizoma Coptidis 5%, Radix Puerariae 4%, Radix Bupleuri 4%, Radix Gentianae 4%, Concha Haliotidis 4%, other each component and constant rate, each component weight sum is 100%.Production method is identical with embodiment 3.
Embodiment 5: when the cause of disease belongs to the turbid impatency of expectorant, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 10%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 6%, Rhizoma Corydalis 8%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 4%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 8%, Radix Glycyrrhizae 6%, the Rhizoma Pinelliae 4%, Bulbus Fritillariae Cirrhosae 6%, each component weight sum is 100%.With the existing method for preparing Chinese medicinal capsule Chinese medicine composition is made capsule.
Embodiment 6: when the cause of disease belongs to the blood stasis resistance heart, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 8%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 6%, Rhizoma Corydalis 6%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 4%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 6%, Radix Glycyrrhizae 4%, succinum 2%, Olibanum %, Myrrha 7%, each composition weight sum is 100%.With the existing method for preparing medicine pill Chinese medicine composition is made pill.
Claims (7)
1, a kind of treatment coronary heart disease, anginal Chinese medicine composition comprise: the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, Fructus Trichosanthis, Ramulus Cinnamomi, Rhizoma Acori Graminei, Radix Polygalae, Semen Ziziphi Spinosae, Radix Glycyrrhizae is characterized in that the shared weight ratio of each component is:
Radix Astragali 10-20%
Radix Salviae Miltiorrhizae 8-16%
Radix Angelicae Sinensis 2-8%
Rhizoma Chuanxiong 2-8%
Flos Carthami 4-8%
Rhizoma Corydalis 4-12%
Rhizoma Atractylodis Macrocephalae 6-10%
Fructus Trichosanthis 7-12%
Ramulus Cinnamomi 2-7%
Rhizoma Acori Graminei 2-10%
Radix Polygalae 2-8%
Semen Ziziphi Spinosae 4-10%
Radix Glycyrrhizae 2-6%.
2, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain Rhizoma Zingiberis, Bulbus Allii Macrostemonis, Rhizoma Zingiberis content is 4～8%, and Bulbus Allii Macrostemonis content is 4-12%.
3, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain crust halberd, Cortex Cinnamomi, crust halberd content is 4-15%, Cortex Cinnamomi 2-8%.
4, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain Radix Scutellariae, Rhizoma Coptidis, Radix Puerariae, Radix Scutellariae content is that 4-12%, Rhizoma Coptidis content are that 4-12%, Radix Puerariae content are 4-12%.
5, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain Radix Bupleuri, Radix Gentianae, Concha Haliotidis, Radix Bupleuri content is that 2-8%, Radix Gentianae content are that 2-8%, Concha Haliotidis content are 4-8%.
6, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain the Rhizoma Pinelliae, Bulbus Fritillariae Cirrhosae, Rhizoma Pinelliae content is that 2-6%, Bulbus Fritillariae Cirrhosae content are 4-9%.
7, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain succinum, Olibanum, Myrrha, succinum content is that 1-4%, Olibanum content are that 4-8%, Myrrha content are 4-12%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94115183A CN1051008C (en) | 1994-09-16 | 1994-09-16 | Chinese medicine composite for coronary heart disease and angina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94115183A CN1051008C (en) | 1994-09-16 | 1994-09-16 | Chinese medicine composite for coronary heart disease and angina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1115658A CN1115658A (en) | 1996-01-31 |
| CN1051008C true CN1051008C (en) | 2000-04-05 |
Family
ID=5037388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94115183A Expired - Fee Related CN1051008C (en) | 1994-09-16 | 1994-09-16 | Chinese medicine composite for coronary heart disease and angina |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1051008C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101485832B (en) * | 2009-01-19 | 2011-08-31 | 陈国来 | Capsule for coronary disease |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100672952B1 (en) * | 2004-06-09 | 2007-01-22 | 퓨리메드 주식회사 | Polygala tenuifolia extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same |
| CN100339093C (en) * | 2005-07-28 | 2007-09-26 | 山东中医药大学 | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process |
| CN102641420B (en) * | 2012-05-15 | 2013-08-21 | 沈长发 | Pharmaceutical composition for treating coronary heart disease |
| CN103638373B (en) * | 2013-11-20 | 2015-07-08 | 蒋学 | Medicine used for treating angina pectoris, and preparation method thereof |
| CN104352810A (en) * | 2014-10-27 | 2015-02-18 | 王志春 | Medicine for treating palpitation and preparation method thereof |
| CN104352854A (en) * | 2014-11-04 | 2015-02-18 | 赵国忠 | Angina pectoris Yang activating, blood circulation promoting and stasis removing preparation and preparation method thereof |
| CN104435853A (en) * | 2014-12-19 | 2015-03-25 | 李建德 | Traditional Chinese medicine composition for treating coronary heart disease |
| CN104645207A (en) * | 2015-03-17 | 2015-05-27 | 朱克兰 | Traditional Chinese medicine composition for treating angina |
| CN104922507A (en) * | 2015-05-31 | 2015-09-23 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with diabetes |
| CN104873685A (en) * | 2015-06-02 | 2015-09-02 | 周红玲 | Medicine for treating coronary heart disease |
| CN105616804A (en) * | 2015-12-30 | 2016-06-01 | 杨桂珍 | Medicine for treating latent coronary heart disease |
| CN106421702A (en) * | 2016-11-01 | 2017-02-22 | 张志明 | Traditional Chinese medicine composite for treating coronary heart disease |
| CN108159213A (en) * | 2018-03-27 | 2018-06-15 | 南阳理工学院 | It is a kind of to be used to treat Chinese medicine composition of coronary heart disease and preparation method thereof |
| CN111870645B (en) * | 2020-07-09 | 2022-04-29 | 何庆勇 | Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1065793A (en) * | 1991-04-15 | 1992-11-04 | 李文升 | A kind of manufacture method of Chinese medicine Zhixindan |
| CN1077125A (en) * | 1993-02-17 | 1993-10-13 | 中国人民解放军第二炮兵西安中医多学科研究所 | A kind of production method for the treatment of the medicine of coronary heart disease |
| CN1082911A (en) * | 1993-02-14 | 1994-03-02 | 天津市医药工业技术研究所 | The new drug of treatment angina pectoris Chinese medicine |
-
1994
- 1994-09-16 CN CN94115183A patent/CN1051008C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1065793A (en) * | 1991-04-15 | 1992-11-04 | 李文升 | A kind of manufacture method of Chinese medicine Zhixindan |
| CN1082911A (en) * | 1993-02-14 | 1994-03-02 | 天津市医药工业技术研究所 | The new drug of treatment angina pectoris Chinese medicine |
| CN1077125A (en) * | 1993-02-17 | 1993-10-13 | 中国人民解放军第二炮兵西安中医多学科研究所 | A kind of production method for the treatment of the medicine of coronary heart disease |
Non-Patent Citations (3)
| Title |
|---|
| 《中西医结合杂志》10(4) 1990. 4.30 王仁平,益气活血方治疗冠心病心绞痛血瘀证30例(摘要) * |
| 《陕西中医》14(8) 1993. 8.31 马战平,中药治疗冠心病53例 * |
| 《陕西中医》14(8) 1993. 8.31 马战平,中药治疗冠心病53例;《中西医结合杂志》10(4) 1990. 4.30 王仁平,益气活血方治疗冠心病心绞痛血瘀证30例(摘要) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101485832B (en) * | 2009-01-19 | 2011-08-31 | 陈国来 | Capsule for coronary disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1115658A (en) | 1996-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1051008C (en) | Chinese medicine composite for coronary heart disease and angina | |
| CN101181600B (en) | Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases | |
| CN1334121A (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN102100788A (en) | Chinese medicinal preparation for preventing and treating chicken coccidiosis | |
| CN104666951A (en) | Traditional Chinese medicine composition for treating parturient paresis puerperal fever | |
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN110960619A (en) | Traditional Chinese medicine composition for treating African swine fever | |
| CN1150018C (en) | Medicine for treating tachy-arrhythmia | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1296832A (en) | Chinese medicine for treating psoriasis | |
| CN104587267A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN1060379C (en) | Chines medicine for treating vitiligo and preparation method thereof | |
| CN101966239B (en) | Chinese medicinal composition for preventing and treating cardiac cerebral and vascular diseases and preparation method thereof | |
| CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN1256138C (en) | Medicine for treating apoplexy and its preparing process | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1063656C (en) | Capsule of peenisetum flaccidum for treating acne and preparing method therefor | |
| CN1028605C (en) | Series medical health chothes and its making method | |
| CN109432316A (en) | For traditional Chinese medicine composition for herpes and preparation method thereof | |
| CN1088589C (en) | Chinese medicine | |
| CN101658661A (en) | Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |